TrialProceedings of the National Academy of Sciences of the United States of America2007

IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.

Chatarina Lofqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.